Cancerworld Magazine
  • About the Magazine
    • About us
    • Editorial Team
    • Events
    • Archive
    • Contacts
  • Articles
    • Policy
    • Practice Points
    • Delivery of Care
    • Biology basic
    • Medicine
    • Featured
  • Contents
    • News
    • Editorials
    • Interviews to the Expert
    • In the Hot Seat
    • Profiles
    • Obituaries
    • Voices
  • ESCO Corner
SUBSCRIBE FOR FREE
Facebook
Twitter
LinkedIn
Cancerworld Magazine
Cancerworld Magazine
  • About the Magazine
    • About us
    • Editorial Team
    • Events
    • Archive
    • Contacts
  • Articles
    • Policy
    • Practice Points
    • Delivery of Care
    • Biology basic
    • Medicine
    • Featured
  • Contents
    • News
    • Editorials
    • Interviews to the Expert
    • In the Hot Seat
    • Profiles
    • Obituaries
    • Voices
  • ESCO Corner
Cancerworld Magazine > Editorials > These COVID days
  • Editorials

These COVID days

  • 15 October 2020
  • Adriana Albini
These COVID days
Total
0
Shares
0
0
0
0
0

‘Tackling cancer in interesting times’ was the theme of my first Editorial for Cancer World. I wrote that at the start of February this year, at a time when Europe remained largely oblivious to the implications of a new virus that had been wreaking havoc in parts of China. Within weeks, the spread of the pandemic, first to Italy and then across Europe, changed our lives as individuals and communities, in ways we had never foreseen, Currently it is hard to predict how long these ‘interesting times’ will continue, and what a new normal, when it comes, will look like.

These are testing times for the cancer community. For patients, above all, whose access to diagnostics, treatment and care has been hit in so many ways, and who have found themselves often isolated – in clinical consultations and in their daily lives – at a time when they most needed support. And for oncology professionals, trying to do their best while lacking the evidence to define ‘best care’ in the COVID setting, working within health systems often ill-prepared to deal with the high number of virus-infected patients, and at a time when social distancing made normal professional collaboration and patient care more difficult, and when many healthcare staff struggled with access to the personal protective equipment and testing needed to keep them and their patients safe.

These are indeed interesting times. But as I wrote in that Editorial, while the (purportedly Chinese) expression “May you live in interesting times” tends to be understood as a curse, evoking a sense of menace, it can also be seen as an invitation to consider the turn of human events in all their complexity.

This pandemic, this global tragedy and trauma, invites us to do just that. It invites us to ask questions about why we were so poorly prepared for this event, when the likelihood – even certainty – of a pandemic on this scale had long been predicted by scientists.

It invites us to count the cost of failing to invest in preventive measures – and to draw the conclusions and make the changes in the way we approach social issues: health, certainly, but also the environment whose intricate connection with health has been demonstrated so catastrophically by this virus.

It invites us to value our health and care workers, who were initially left holding the frontline against this global threat, understaffed and underequipped, at a great cost to their health, mental health and too often, their lives. Not just with applause and media eulogies to their heroism, but with a pledge that never again should we require such sacrifice to deal with a threat that was foreseeable and foreseen.

It invites us to integrate into our new normal everything we’ve learnt about using information technology to communicate, collaborate and teach remotely, and about the value of interdisciplinarity – looking for answers among classic ‘repurposed’ or innovative molecules developed for other diseases; virologists and oncologists learning from one another.

And at a time when facemasks and social distancing are putting up additional barriers, it invites health professionals, not least in oncology, to identify closer with their patients, recognising that the sense of fear and vulnerability in the face of a disease that we don’t fully understand, or know how to treat, or even how to avoid, is common to us all.

Illustration by Vito Manolo Roma

Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Related Topics
  • covid-19
  • health professionals
  • humanity
  • interdisciplinarity
  • prevention
Adriana Albini

Adriana Albini is scientific collaborator at the European Institute of Oncology (IEO) in Milan, Professor of General Pathology at the Milan Bicocca University, she has been deputy Chief of Genoa Cancer Center and Head of Research Department of Reggio Emilia Cancer Center and Scientific Director of MultiMedica Onlus.

Previous Article
  • Articles
  • Delivery of Care

Delivering cancer care during the pandemic: lessons from the ‘first wave’

  • 7 October 2020
  • Anna Wagstaff
View Post
Next Article
  • News

Four steps to eliminating HPV-related cancers: a call for action

  • 16 October 2020
  • Janet Fricker
View Post
You May Also Like
View Post
  • Editorials

Leave no-one behind

  • Matti Aapro
  • 17 November 2022
View Post
  • Editorials

Pandemics, War, Reconstruction and the Duty of Medicine and Science

  • Adriana Albini
  • 4 April 2022
View Post
  • Editorials

A fair chance for women in oncology: we must all insist on change

  • Adriana Albini
  • 18 February 2022
View Post
  • Editorials

Returning to ‘normal’ and beating cancer in Europe 2021

  • Adriana Albini
  • 3 June 2021
View Post
  • Editorials

Adriana Albini, editor in chief, presents Cancer World issue 89

  • Adriana Albini
  • 12 November 2020
View Post
  • Editorials

Tackling cancer in interesting times

  • Adriana Albini
  • 4 February 2020
search
CancerWorld #101 Download CancerWorld #101 Download CancerWorld #101 Download or search in Cancerworld archive
Newsletter

Subscribe free to
Cancerworld!

We'll keep you informed of the latest features and news with a fortnightly email

Subscribe now
Latest News
  • Personalised neoantigen vaccine for kidney cancer shows promise in phase 1 study
    • 8 May 2025
  • What Caught Our Eye in April: Oncology’s Top Moments
    • 7 May 2025
  • CancerWorld #102 (April 2025)
    • 22 April 2025
  • What Caught Our Eye in March: Oncology’s Top Moments
    • 8 April 2025
  • Ovarian cancer: mechanism conferring resistance to immunotherapy revealed
    • 21 March 2025
Article
  • Miriam Merad and the 2025 Sjöberg Prize: A Celebration of Innovation in Cancer Immunotherapy
    • 6 May 2025
  • Istanbul, Ankara take action on HPV vaccination, as government delays promised national programme
    • 1 April 2025
  • Could this dual approach be the frontier that finally gets immunotherapy to work for MSS colorectal cancer?
    • 31 March 2025
Social

Would you follow us ?

Contents
  • Miriam Merad and the 2025 Sjöberg Prize: A Celebration of Innovation in Cancer Immunotherapy
    • 6 May 2025
  • “I really care about people.” – Philip Kantoff, A Life in Science and Medicine
    • 5 May 2025
  • What If the World’s Leading Prostate Cancer Epidemiologist Opened a Restaurant? A Conversation with Lorelei Mucci- A Harvard Scientist, A Mother, A Leader
    • 23 April 2025
MENU
  • About the Magazine
    • About us
    • Editorial Team
    • Events
    • Archive
    • Contacts
  • Articles
    • Policy
    • Practice Points
    • Delivery of Care
    • Biology basic
    • Medicine
    • Featured
  • Contents
    • News
    • Editorials
    • Interviews to the Expert
    • In the Hot Seat
    • Profiles
    • Obituaries
    • Voices
  • ESCO Corner
Cancerworld Magazine
  • About us
  • Articles
  • Media Corner
  • Privacy Policy
  • Cookie Policy

Cancerworld is published by OncoDaily (P53 Inc.) | Mailing Address: 867 Boylston st, 5th floor, Ste 1094 Boston, MA 02116, United States | [email protected]

Archivio Cancerworld

Input your search keywords and press Enter.